
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
Anne-Noëlle Frix, Liam G. Heaney, Barbro Dahlén, et al.
ERJ Open Research (2022) Vol. 8, Iss. 4, pp. 00273-2022
Open Access | Times Cited: 13
Anne-Noëlle Frix, Liam G. Heaney, Barbro Dahlén, et al.
ERJ Open Research (2022) Vol. 8, Iss. 4, pp. 00273-2022
Open Access | Times Cited: 13
Showing 13 citing articles:
Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient
Linda Rogers, Miloš Jeseňák, Leif Bjermer, et al.
Respiratory Medicine (2023) Vol. 218, pp. 107414-107414
Open Access | Times Cited: 25
Linda Rogers, Miloš Jeseňák, Leif Bjermer, et al.
Respiratory Medicine (2023) Vol. 218, pp. 107414-107414
Open Access | Times Cited: 25
Benralizumab Outcomes in Patients with Severe Eosinophilic Asthma Treated in Real-Life Settings: Results of the BREEZE Study in 5 Countries From Central Eastern Europe and Baltics
Florin Mihălţan, Zsuzsanna Csoma, Norbert Pauk, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 195-210
Open Access
Florin Mihălţan, Zsuzsanna Csoma, Norbert Pauk, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 195-210
Open Access
Severe asthma care trajectories: the French RAMSES cohort
Jeanne‐Marie Perotin, Lisa Gauquelin, N. Just, et al.
ERJ Open Research (2024) Vol. 10, Iss. 2, pp. 00837-2023
Open Access | Times Cited: 4
Jeanne‐Marie Perotin, Lisa Gauquelin, N. Just, et al.
ERJ Open Research (2024) Vol. 10, Iss. 2, pp. 00837-2023
Open Access | Times Cited: 4
Combination of Biological Therapy in Severe Asthma: Where We Are?
Lorenzo Carriera, Marta Fantò, Alessia Martini, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1594-1594
Open Access | Times Cited: 10
Lorenzo Carriera, Marta Fantò, Alessia Martini, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1594-1594
Open Access | Times Cited: 10
Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy
Moritz Z. Kayser, Hendrik Suhling, Jan Fuge, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Moritz Z. Kayser, Hendrik Suhling, Jan Fuge, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Real-World Safety Profile of Biologic Drugs for Severe Uncontrolled Asthma: A Descriptive Analysis from the Spanish Pharmacovigilance Database
Carlos Boada-Fernández-del-Campo, Marcelino García-Sánchez-Colomer, Eduardo Fernández-Quintana, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4192-4192
Open Access | Times Cited: 2
Carlos Boada-Fernández-del-Campo, Marcelino García-Sánchez-Colomer, Eduardo Fernández-Quintana, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4192-4192
Open Access | Times Cited: 2
Characteristics of severe asthma patients on biologics: a real-life European registry study
Stefania Principe, Levi B. Richards, Simone Hashimoto, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00586-2022
Open Access | Times Cited: 5
Stefania Principe, Levi B. Richards, Simone Hashimoto, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00586-2022
Open Access | Times Cited: 5
Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma Register
Marianne Baastrup Soendergaard, Susanne Hansen, Anne‐Sofie Bjerrum, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 1, pp. 146-155.e5
Open Access | Times Cited: 5
Marianne Baastrup Soendergaard, Susanne Hansen, Anne‐Sofie Bjerrum, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 1, pp. 146-155.e5
Open Access | Times Cited: 5
International Severe Asthma Registry
Éric Van Ganse, Renaud Louis
CHEST Journal (2024) Vol. 166, Iss. 1, pp. 3-4
Closed Access | Times Cited: 1
Éric Van Ganse, Renaud Louis
CHEST Journal (2024) Vol. 166, Iss. 1, pp. 3-4
Closed Access | Times Cited: 1
Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
Hendrik Suhling, Dirk Skowasch, Karl‐Christian Bergmann, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 12, pp. 100844-100844
Open Access | Times Cited: 2
Hendrik Suhling, Dirk Skowasch, Karl‐Christian Bergmann, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 12, pp. 100844-100844
Open Access | Times Cited: 2
Outcome measures in asthma attack trials: can't see the good for the wheeze
Richard Russell
ERJ Open Research (2024) Vol. 10, Iss. 1, pp. 01036-2023
Open Access
Richard Russell
ERJ Open Research (2024) Vol. 10, Iss. 1, pp. 01036-2023
Open Access
German Asthma Net – Was haben wir bisher gelernt?
Mandy Seefeldt, Roland Buhl, Eckard Hamelmann, et al.
Zeitschrift für Pneumologie (2023) Vol. 20, Iss. 2, pp. 88-93
Closed Access | Times Cited: 1
Mandy Seefeldt, Roland Buhl, Eckard Hamelmann, et al.
Zeitschrift für Pneumologie (2023) Vol. 20, Iss. 2, pp. 88-93
Closed Access | Times Cited: 1
Biologic treatment eligibility and characteristics of Romanian patients with severe asthma: Real-world data from the RECOGNISE study
Dragos Nicolosu, Dragos Gabriel Ungureanu, Violeta Perlea, et al.
Pneumologia (2023) Vol. 72, Iss. 1, pp. 105-118
Open Access
Dragos Nicolosu, Dragos Gabriel Ungureanu, Violeta Perlea, et al.
Pneumologia (2023) Vol. 72, Iss. 1, pp. 105-118
Open Access